Gfi1 was originally identified as a frequent target of proviral insertion in T and B cell lymphomas [6]–[12], which resulted in the activation of Gfi1 at both the transcriptional and post-transcriptional levels [13], [14]. This evidence concerns the gene GFI1 and B-cell non-Hodgkin lymphoma.